Financials data is unavailable for this security.
View more
Year on year Carl Zeiss Meditec AG had little change in net income (from 293.91m to 290.40m) despite revenues that grew 9.80% from 1.90bn to 2.09bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 40.74% to 42.29%.
| Gross margin | 55.12% |
|---|---|
| Net profit margin | 9.84% |
| Operating margin | 12.87% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in EURView more
In 2023, Carl Zeiss Meditec AG increased its cash reserves by 37.16%, or 2.87m. The company earned 250.86m from its operations for a Cash Flow Margin of 12.01%. In addition the company used 110.98m on investing activities and also paid 135.09m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in EURView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in EUR
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -1.20%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked above the industry average relative to its peers.
| Div yield(5 year avg) | 0.75% |
|---|---|
| Div growth rate (5 year) | 14.87% |
| Payout ratio (TTM) | 48.42% |
| EPS growth(5 years) | 18.09 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -33.66 |
More ▼
